Routine immunization services resume at Walgreens

Article

Walgreens announces that routine immunization service will resume.

Earlier this year Walgreens announced that it was going to postpone all nonurgent, routine immunizations because of the COVID-19 pandemic. On June 22, 2020, the company announced that it would be resuming the services. The Centers for the Disease Control and Prevention had recent issued guidance emphasizing the need to get routine immunizations.

Several precautions will be taken to protect both patient and pharmacy staff including the wearing of personal protective equipment by pharmacy staff, maintaining social distancing during paperwork and waiting, and the providing face masks for patients who are not already wearing one.

For more on the company’s announcement, please see our sister publication Drug Topics.

Recent Videos
Jillian Cotter, MD
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Tina Tan, MD
Danielle Van Damme, DNP, CPNP-AC
Karen Y. Capusan, DNP, CPNP-PC
Measles outbreaks: 223 cases reported in Texas | Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Tina Tan, MD
Related Content
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children

Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children

Tina Q Tan, MD, FAAP, FIDSA, FPIDS
May 23rd 2025
Article

Our editor-in-chief Tina Tan, MD, reacts to a new FDA COVID-19 framework that will limit eligibility for seasonal vaccination in pediatrics.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

FDA approves NVX-CoV2705 COVID-19 vaccine | Image credit: Contemporary Pediatrics

FDA approves NVX-CoV2705 COVID-19 vaccine

Joshua Fitch, Senior Editor
May 19th 2025
Article

NVX-CoV2705 is indicated for individuals aged 12 to 64 years with an underlying condition that poses high risk for severe COVID-19 outcomes.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

USPSTF: Syphilis screening during pregnancy has 'substantial' net benefit | Image Credit: © Kostia - © Kostia - stock.adobe.com.

USPSTF: Syphilis screening during pregnancy has 'substantial' net benefit

Joshua Fitch, Senior Editor
May 14th 2025
Article

The nearly 4000 cases in 2023 were the highest number reported in over 30 years, the Task Force stated.

Infant RSV hospitalization rates 28%, 43% lower this season vs pre-COVID seasons | Image Credit: © MargJohnsonVA - © MargJohnsonVA - stock.adobe.com.

Infant RSV hospitalization rates 28%, 43% lower this season vs pre-COVID seasons

Joshua Fitch, Senior Editor
May 9th 2025
Article

"These findings support Advisory Committee on Immunization Practices’ recommendations for maternal vaccination or nirsevimab to protect against severe RSV disease in infants," wrote the MMWR study investigators.

© 2025 MJH Life Sciences

All rights reserved.